Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee

How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its extensive supply chain?

President Donald Trump is poised to sign the first bill of his new administration. It's named after a slain Georgia nursing student whose name became a rallying cry during his White House campaign.

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and challenges as it positions itself for long-term growth. Recent financial reports and analyst assessments paint a picture of a company leveraging its strong oncology portfolio and innovative medicine segment to offset headwinds in other areas.

Whether Ben Johnson and Ryan Poles think it's a top priority isn't known but the new Bears coach threw out a position they could stand to 'augment.'

Ben Johnson doesn't need clichés to get his point across, nor does he want anything that he didn't earn. He's the right guy for the Chicago Bears. What's better is that he knows it, too.

We are not going to be intimidated by those acts of terror to radically shift our way of living,” Mayor Brandon Johnson said. “That’s what individuals who stoke fear into people want to see happen.”

With Ben Johnson off to be the head coach of the Chicago Bears, the Lions will need a new voice to lead the offense. Johnson's move to the division rival has frustrated some fans, and left pundits wondering if there was friction amongst Dan Campbell's coaching staff.